United States Medical Licensing Examination

Notable Labs Closes Merger Transaction With VBL Therapeutics

Retrieved on: 
Monday, October 16, 2023
Machine learning, Founders Fund, Association of British HealthTech Industries, Apoptosis, Builder, United States Medical Licensing Examination, AML, VBL, Cancer, Induced cell cycle arrest, CUSIP, Therapy, PLK1, Acute myeloid leukemia, First Round Capital, Y Combinator, Patient, Security (finance), Pharmaceutical industry, Notability, Volasertib

- Completed previously announced $10.3 million private placement with leading healthtech-focused investors, led by Builders VC, B Capital Group, Y Combinator, First Round Capital, and Founders Fund -

Key Points: 
  • - Completed previously announced $10.3 million private placement with leading healthtech-focused investors, led by Builders VC, B Capital Group, Y Combinator, First Round Capital, and Founders Fund -
    FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced the completion of its merger transaction with VBL Therapeutics (“VBL”) (Nasdaq: VBLT) and associated financing.
  • “This is an important milestone for Notable as we continue to advance the demonstrated value of the PPMP,” said Thomas Bock, M.D., Chief Executive Officer of Notable.
  • “The merger will add additional capital to accelerate our continued development of Volasertib for the treatment of AML in PPMP-predicted responding patients.
  • PPMP has guided Notable in the selection and development of two clinical-stage therapeutic candidates in platform-predicted responding patients with AML.

M42 Announces New Clinical LLM to Transform the Future of AI in Healthcare

Retrieved on: 
Thursday, October 12, 2023
Technology, Professional Services, Other Health, Health, Health Technology, Research, Data Analytics, Software, Artificial Intelligence, Science, Hardware, Partnership, Abu Dhabi Department of Education and Knowledge, Zawar Farid, USMLE, AI, Ethics, Data, Safety, Pharmacist, Memory, Patient, Artificial intelligence, MBZUAI, Hussain Al Nowais, CS-2, G42, ChatGPT, Literature, United States Medical Licensing Examination, Condor, LLM, Genomics, Life, Medical device, Nursing, Cerebras, M42

M42, a global tech-enabled healthcare network, has unveiled an impactful advancement in healthcare technology with the launch of Med42, a new open-access Clinical Large Language Model (LLM).

Key Points: 
  • M42, a global tech-enabled healthcare network, has unveiled an impactful advancement in healthcare technology with the launch of Med42, a new open-access Clinical Large Language Model (LLM).
  • The 70 billion parameter, generative artificial intelligence (AI) model is poised to transform the future of AI across the healthcare sector and create a direct impact on patient care outcomes.
  • The model has been developed to exponentially enhance clinical decision-making and increase access to synthesized medical knowledge for healthcare professionals, patients, and medical researchers through to regulators.
  • M42 aims to catalyze global innovation in AI for healthcare, empowering experts across the globe to refine and expand the model's applications in various medical domains.

M42 Announces New Clinical LLM to Transform the Future of AI in Healthcare

Retrieved on: 
Thursday, October 12, 2023
Partnership, Hugging Face, Abu Dhabi Department of Education and Knowledge, Research, USMLE, AI, Ethics, Data, Safety, Pharmacist, Health, Memory, Meta, Patient, Artificial intelligence, MBZUAI, ABU, Hussain Al Nowais, CS-2, G42, ChatGPT, Literature, United States Medical Licensing Examination, Condor, LLM, Genomics, Life, United Arab Emirates, Medical device, Nursing, Cerebras, M42

The 70 billion parameter, generative artificial intelligence (AI) model is poised to transform the future of AI across the healthcare sector and create a direct impact on patient care outcomes.

Key Points: 
  • The 70 billion parameter, generative artificial intelligence (AI) model is poised to transform the future of AI across the healthcare sector and create a direct impact on patient care outcomes.
  • The model has been developed to exponentially enhance clinical decision-making and increase access to synthesized medical knowledge for healthcare professionals, patients, and medical researchers through to regulators.
  • Med42 has the potential to revolutionize the pace of clinical decision-making, acting as an AI assistant for healthcare professionals.
  • Today, we helped bring another state-of-the-art LLM to the world, Med42, with huge benefits for the healthcare landscape."

Ziff Davis & Xyla Partner to Drive Innovation Using Artificial Intelligence; Initial Focus in Healthcare Vertical

Retrieved on: 
Wednesday, August 2, 2023
Internet, Health, Media, Artificial Intelligence, Data Management, Communications, Health Technology, Technology, Ziff, Partnership, Clinical trial, Ziff Davis, United States Medical Licensing Examination, Machine learning, Single-use medical devices, Artificial intelligence, ZD, Information services, Software, Sales, Medical device, AI, Xyla Foxlin

Ziff Davis is purchasing $25 million of Xyla equity for a minority ownership stake in the company.

Key Points: 
  • Ziff Davis is purchasing $25 million of Xyla equity for a minority ownership stake in the company.
  • A portion of the investment will be funded with cash and a portion of the investment will be funded with Ziff Davis common stock with Xyla leadership exchanging a portion of their Xyla shares for Ziff Davis common stock.
  • Ziff Davis and Xyla are entering into a long-term collaboration agreement that establishes a framework for the parties to rapidly define, develop, and deploy AI at discrete brands and businesses within the Ziff Davis portfolio.
  • We have assembled a world-class team of experts in AI, and machine learning broadly, who are excited to partner with Ziff Davis.”

OpenEvidence AI Becomes the First AI in History to Score Above 90% on the United States Medical Licensing Examination (USMLE)

Retrieved on: 
Friday, July 14, 2023
Approximation error, LLM, USMLE, AIS, Partnership, Mayo Clinic, Life, The New England Journal of Medicine, ChatGPT, Cancer, United States Medical Licensing Examination, Intelligence, Medicine, Multimedia, MIT, History, Harvard University, Doctor of Philosophy, Harvard Medical School, Patient, Terrance, BMJ, Artificial intelligence, Single-use medical devices, Death, Conference, Social media, Medical device, Health, Learning, AI

CAMBRIDGE, Mass., July 14, 2023 /PRNewswire/ -- OpenEvidence, a generative Artificial Intelligence (AI) company working on aligning Large Language Models (LLMs) to the medical domain, announced today that OpenEvidence AI has become the first AI in history to score above 90% on the United States Medical Licensing Examination (USMLE).

Key Points: 
  • CAMBRIDGE, Mass., July 14, 2023 /PRNewswire/ -- OpenEvidence, a generative Artificial Intelligence (AI) company working on aligning Large Language Models (LLMs) to the medical domain, announced today that OpenEvidence AI has become the first AI in history to score above 90% on the United States Medical Licensing Examination (USMLE).
  • "The horizon of the possible in Artificial Intelligence (AI) has been redefined yet again, as OpenEvidence AI becomes the first AI in history to score above 90% on the United States Medical Licensing Examination (USMLE).
  • "A widely cited study published in the BMJ in 2016 estimated that medical errors were the third leading cause of death in the United States, after heart disease and cancer.
  • The USMLE is a three-step examination for medical licensure in the United States.

Munjal Shah Earns WTF Innovators Award

Retrieved on: 
Wednesday, June 28, 2023
USMLE, Optimism, Johns Hopkins Hospital, LLM, Synthetic media, Marie Cassidy, Stanford University, Fantastic Voyage: Live Long Enough to Live Forever, E-commerce, Cardiology, SALT, Washington University in St. Louis, Health, Social, United States Medical Licensing Examination, Medicare, Hippocrates, Reinforcement, Patient, Physician, Nursing, HGI, Artificial intelligence, AI, Empathy, Medical device, Nvidia

SALT LAKE CITY, June 28, 2023 /PRNewswire/ -- QuHarrison Terry presents Munjal Shah, Co-founder & CEO of Hippocratic AI , with the WTF Innovators Award for his mission to create a healthcare-focused LLM that engages patients, aids physicians, and educates medical students.

Key Points: 
  • SALT LAKE CITY, June 28, 2023 /PRNewswire/ -- QuHarrison Terry presents Munjal Shah, Co-founder & CEO of Hippocratic AI , with the WTF Innovators Award for his mission to create a healthcare-focused LLM that engages patients, aids physicians, and educates medical students.
  • The WTF Innovators Award recognizes excellence at the precipice of societal change, with the inaugural class focusing on AI innovators.
  • As a memento, each of the 34 awardees are gifted a featured song by QuHarrison Terry and Genesis Renji.
  • We present "Live Long", produced by Nimso , to Munjal Shah.

USMLE Step 1 Changes Prompt TrueLearn to Launch New Faculty Platform

Retrieved on: 
Tuesday, May 30, 2023
Campbell, Curriculum, Faculty, USMLE Step 1, USMLE, DEI, United States Medical Licensing Examination, Student, Research, Risk, Tutoring, Nursing

To help medical schools easily predict which learners might be at risk for failing Step 1 and how to optimize performance on Step 2, TrueLearn, a leading healthcare digital learning and analytics platform, has launched new technologies that enable programs to put measures in place to improve both outcomes and residency match rates. With TrueLearn, programs can easily monitor how their learners will perform on Step 1, Step 2, and Subject Exams, identify any gaps in their curriculum, and compare longitudinal trends by cohort, year, and exam -- all in real-time from a centralized location.

Key Points: 
  • A recent study shows the majority of learners are spending less time studying for USMLE Step 1, and medical schools are noticing a difference.
  • (2)
    "We are finding that many learners aren't preparing as much for USMLE Step 1, and that deficit will create a trickling effect," explained TrueLearn CCO Kate Campbell.
  • "Research shows that historically high Step 1 scores have a positive impact on Step 2 outcomes and that there is a significant correlation between scoring high on Step 1 and passing Step 2 on the first try."
  • Available today, TrueLearn's digital learning platform is powered by a robust analytics engine and includes an innovative USMLE solution that connects students and faculty.

Medical Students at 10 Schools Receive Free Access to Next-Gen Study Planner for USMLE Exams

Retrieved on: 
Wednesday, May 17, 2023
Learning, USMLE, Partnership, Calendar, Keck School of Medicine of USC, USC, Time management, Assistant, United States Medical Licensing Examination, School, Student, Blueprint, Patient, COMLEX, Entrepreneurship, LOS, Nursing, State University of New York Upstate Medical University

LOS ANGELES, May 17, 2023 /PRNewswire/ -- Blueprint Prep, the leading platform for innovative test prep and tutoring solutions, recently announced a resource agreement it formed with ten medical schools — USC Keck, SUNY Upstate, San Juan Bautista, and PONCE to name a few. Under the agreement, students at the schools will have free access to Cram Fighter, Blueprint Prep's all-in-one, customizable study planner, to help them manage hectic schedules and stay on top of their USMLE exam requirements.

Key Points: 
  • Blueprint Prep's customizable tool helps medical school students organize their study schedules for USMLE exams to manage stress and keep from being overwhelmed.
  • Under the agreement, students at the schools will have free access to Cram Fighter, Blueprint Prep's all-in-one, customizable study planner, to help them manage hectic schedules and stay on top of their USMLE exam requirements.
  • Navigating a medical school curriculum involves a massive amount of learning, with dense course content piled on top of preparation for medical exams like USMLE (United States Medical Licensing Examination), COMLEX (Comprehensive Osteopathic Medical Licensure Examination) and Shelf Exams.
  • If you are a faculty member at a medical school and would like to inquire about getting Cram Fighter for your students, please visit https://blueprintprep.com/medical/institutions .

Aerami Therapeutics Mourns the Sudden Loss of Chief Executive Officer Lisa Yañez

Retrieved on: 
Friday, May 5, 2023
Chairperson, Pulmonary hypertension, Shoulder, Family, Friends, Patient, United States Medical Licensing Examination, Nursing

DURHAM, N.C., May 05, 2023 (GLOBE NEWSWIRE) -- It is with deep sadness that Aerami Therapeutics (“Aerami”) today announces that our dear friend, fierce patient advocate, dedicated mentor, and CEO, Lisa Yañez suddenly passed away on Tuesday, May 2, 2023.

Key Points: 
  • DURHAM, N.C., May 05, 2023 (GLOBE NEWSWIRE) -- It is with deep sadness that Aerami Therapeutics (“Aerami”) today announces that our dear friend, fierce patient advocate, dedicated mentor, and CEO, Lisa Yañez suddenly passed away on Tuesday, May 2, 2023.
  • The entire Aerami community mourns the loss of Lisa and extends our deepest sympathies to her family during this difficult time.
  • Effective immediately, Anne Whitaker, Executive Chairwoman of the Board of Directors, will step in to lead Aerami and ensure all operations move forward as planned.
  • Ms. Whitaker issued the following statement on behalf of the Aerami community: “We and everyone who knew Lisa Yañez have suffered a major loss with her passing.

Osteopathic Medical Students Find Residency in Record Numbers

Retrieved on: 
Monday, April 24, 2023
Tuition Assistance Program, COMLEX-USA, USMLE, DOS, Osteopathic medicine in the United States, GI Bill Tuition Fairness Act of 2013, SOAP, Face, United States Medical Licensing Examination, Licensure, GME, Organization, Congress, Osteopathy, DO, Student, NRMP, AACOM, Office, American Association of Colleges of Osteopathic Medicine, Urology, FAIR, Legislation, Nursing, MD

Bethesda, MD, April 24, 2023 (GLOBE NEWSWIRE) -- Today the American Association of Colleges of Osteopathic Medicine (AACOM) announced that an all-time high 7776 graduating osteopathic medical students (DOs) landed residency positions in 2023.

Key Points: 
  • Bethesda, MD, April 24, 2023 (GLOBE NEWSWIRE) -- Today the American Association of Colleges of Osteopathic Medicine (AACOM) announced that an all-time high 7776 graduating osteopathic medical students (DOs) landed residency positions in 2023.
  • “The entire osteopathic medical community is proud of our students’ commitment, tenacity and success,” said Robert Cain, DO, President and CEO of AACOM.
  • “To achieve these numbers even with a record number of medical students looking for placements, is a testament to our colleges of osteopathic medicine and to the abilities and talents of our students.”
    These final placement numbers reflect all the avenues graduating students have for residency placement.
  • DO students take the Comprehensive Osteopathic Medical Licensing Examination of the United States (COMLEX-USA) for graduation and licensure.